ENDOLOGIX INC - NOTE 2.250%12/1 Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2018

Type / Class
Debt / NOTE 2.250%12/1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ENDOLOGIX INC - NOTE 2.250%12/1 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2018 Q4 $0 $0 -$17,088,000 0
2018 Q3 $17,489,237 $17,088,000 -$625,241 97.96% 8
2018 Q2 $18,110,262 $17,874,000 +$92,293 98.6% 10
2018 Q1 $18,068,876 $17,447,000 +$32,853 97.19% 12
2017 Q4 $18,045,513 $17,376,000 +$101,000 96.26% 10
2017 Q3 $17,941,513 $17,174,000 -$244,960 95.74% 9
2017 Q2 $18,206,513 $17,387,000 -$64,622,724 95.66% 12
2017 Q1 $85,303,600 $82,172,000 -$975,200 96.33% 14
2016 Q4 $86,349,000 $77,905,000 -$816,954 90.13% 16
2016 Q3 $85,809,000 $82,528,000 -$268,806 96.44% 15
2016 Q2 $86,751,000 $80,006,000 +$919,330 92.0% 18
2016 Q1 $86,866,000 $63,529,000 +$217,842 73.0% 17
2015 Q4 $86,106,000 $71,881,000 -$472,156 82.32% 18
2015 Q3 $86,246,000 $77,460,000 -$195,410 89.4% 19
2015 Q2 $86,176,000 $83,617,000 +$6,854,680 96.36% 19
2015 Q1 $82,469,000 $82,976,000 +$313,713 100.0% 19
2014 Q4 $82,187,000 $80,946,000 +$937,051 98.03% 17
2014 Q3 $82,423,000 $73,762,000 -$553,247 89.74% 19
2014 Q2 $76,773,000 $76,653,000 +$62,614 100.1% 17
2014 Q1 $82,778,000 $79,245,000 -$300,588 95.4% 20